A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients. 1991

D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
Department of Surgery, Washington University School of Medicine, St Louis, MO 63110.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
July 1992, Transplantation,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
March 1988, Transplantation,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
February 1991, Transplantation proceedings,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
June 1990, Archives of surgery (Chicago, Ill. : 1960),
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
February 1993, Transplantation proceedings,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
June 1986, Transplantation,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
September 1992, Transplantation,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
January 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
November 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation,
D W Hanto, and M D Jendrisak, and C S McCullough, and S K So, and J W Marsh, and T Rush, and S Michalski, and D Phelan, and T Mohanakumar
June 1993, Pediatric nephrology (Berlin, Germany),
Copied contents to your clipboard!